(fra Kommisjonens initiativ)

Restriction updating Annex XVII REACH regarding CMRs (2025)

Draft act

Feedback period: 09 January 2026 - 06 February 2026

Draft regulation - Ares(2026)214185

fra forslagets fortale:

(1) Entries 28, 29 and 30, set out in the Table of Annex XVII to Regulation (EC) No 1907/2006, prohibit the placing on the market and use, for supply to the general public, of substances that are classified as carcinogen, germ cell mutagen or reproductive toxicant (CMR) category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council, and that are listed in Appendices 1 to 6 of Annex XVII to Regulation (EC) No 1907/2006, and of mixtures containing such substances in specified concentrations. 

(2) Regulation (EC) No 1272/2008 as amended by Commission Delegated Regulations (EU) 2024/2564 and (EU) 2025/12224included new harmonised classifications of substances as CMR categories 1A and 1B. Furthermore, Delegated Regulation (EU) 2024/2564 replaced certain entries for reproductive toxicant category 1B with new ones. It is therefore appropriate to update Appendices 1, 2, 4 and 6 of Annex XVII to Regulation (EC) No 1907/2006 to include the newly classified substances and to replace existing entries. 

(3) The amendments to Regulation (EC) No 1272/2008 by Delegated Regulation (EU) 2024/2564 will apply from 1 May 2026. The amendments to Regulation (EC) No 1272/2008 by Delegated Regulation (EU) 2025/1222 will apply from 1 February 2027. Since this Regulation will enter into force after 1 May 2026, the restriction introduced by this Regulation as regards the substances classified by Delegated Regulation (EU) 2024/2564 as CMR categories 1A and 1B should apply from the date of entry into force of this Regulation. In contrast, the restriction as regards the substances classified by Delegated Regulation (EU) 2025/1222 as CMR categories 1A and 1B should apply from 1 February 2027. The date of application of this Regulation does not prevent operators from applying earlier the restrictions related to CMR categories 1A and 1B listed in the Annexes to Delegated Regulations (EU) 2024/2564 and (EU) 2025/1222. 

(4) The CAS numbers listed for three substances referred to in Appendices 1 and 2 of Annex XVII to Regulation (EC) No 1907/2006 should be updated to reflect the up-todate identification of those three substances and ensure clarity and accuracy in the application of the restriction. 

(5) Appendix 6 of this Regulation includes dinitrogen oxide (EC No 233-032-0; CAS No 10024-97-2) because of its classification as reproductive toxicant category 1B. However, the substance is authorised as food additive nitrous oxide (E 942) in accordance with Regulation (EC) No 1333/2008. In particular, in accordance with Annexes II and III to that Regulation that substance may be placed on the market and used in all categories of foods and in food additives, in food enzymes and in food flavourings at quantum satis. Its use as a food additive is subject to safety reevaluation by the European Food Safety Authority (EFSA) as part of the re-evaluation programme provided for in Commission Regulation (EU) No 257/2010. A derogation from the restriction is appropriate to allow the use of dinitrogen oxide by the general public as a food additive as well as the presence of the substance in food. If necessary, the Commission should be able to propose a revision of the derogation in a future update of the restriction based on the outcome of the EFSA assessment. 

(6) As highlighted by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), dinitrogen oxide is also known to be abused as a drug, leading to poisonings and concerns, including regarding neurotoxicity, from frequent or heavy inhalation of the substance. However, this Regulation is not specifically targeted at preventing the abuse of dinitrogen oxide as a drug or at addressing the abovementioned hazardous property of dinitrogen oxide. Nevertheless, when granting a derogation to allow the use of dinitrogen oxide as a food additive, the possibility that the derogation could be exploited for the sale of the substance as a drug should be taken into account. On the one hand, cartridges containing dinitrogen oxide could be misused. On the other hand, aerosol dispensers with dinitrogen oxide do not provide ready access to the substance and are therefore unlikely to be misused. Therefore, to minimise the possibility of misuse, the derogation should include specific conditions for the sale of cartridges containing this substance, such as restrictions on the maximum volume of the substance that can be sold to members of the general public, as well as age restrictions on the sale of the cartridges containing the substance. 

(7) This Regulation is without prejudice to other regulatory frameworks, including national legislation of Member States, that may set stricter measures to address the abuse of dinitrogen oxide as a drug. 

(8) The derogation from the provisions set out in entry 30, set out in Table 1 of Annex XVII to Regulation (EC) No 1907/2006, granted by entry 1 of Appendix 11 of Annex XVII to that Regulation, has ended on 1 June 2013, and should therefore be deleted. 

(9) Regulation (EC) No 1272/2008 requires that, for the purposes of classification, the concentration of a classified substance in a mixture should be considered, and where applicable, the sum of the concentrations of individual classified substances should also be taken into account, in accordance with the additivity rules set out in Annex I, and Part 1 of Annex VI, to that Regulation. Entries 28, 29 and 30, set out in Table 1 of Annex XVII to Regulation (EC) No 1907/2006, should therefore be amended to ensure that the restriction follows the additivity rules set out in Regulation (EC) No 1272/2008, thereby maintaining consistency and coherence with Regulation (EC) No 1272/2008. 

(10) The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 133(1) of Regulation (EC) No 1907/2006,